By Dominic Chopping Shares in Ozempic maker Novo Nordisk topped the Stoxx Europe 600 index after the company said its weight-loss drug also showed success in…
Markets – MarketWatch
Novo Nordisk’s Ozempic Drug Shows Success in Kidney Trial, Boosting Shares Markets – MarketWatch
